Cargando…
Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of dementia (PDD) varies across the different cutoff schemes allowed. A longitudinal study followed 121 non-demented PD pati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516585/ https://www.ncbi.nlm.nih.gov/pubmed/28725690 http://dx.doi.org/10.1038/npjparkd.2015.27 |
_version_ | 1783251186933039104 |
---|---|
author | Wood, Kyla-Louise Myall, Daniel J Livingston, Leslie Melzer, Tracy R Pitcher, Toni L MacAskill, Michael R Geurtsen, Gert J Anderson, Tim J Dalrymple-Alford, John C |
author_facet | Wood, Kyla-Louise Myall, Daniel J Livingston, Leslie Melzer, Tracy R Pitcher, Toni L MacAskill, Michael R Geurtsen, Gert J Anderson, Tim J Dalrymple-Alford, John C |
author_sort | Wood, Kyla-Louise |
collection | PubMed |
description | The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of dementia (PDD) varies across the different cutoff schemes allowed. A longitudinal study followed 121 non-demented PD patients for up to 4.5 years. In Part One, unique groups of patients were identified as PD-MCI at baseline using the MDS-TF requirement of two impaired cognitive test scores, with both scores classified as impaired at either (i) 2 s.d., (ii) 1.5 s.d. or (iii) 1 s.d. below normative data; relative risk (RR) of PDD was assessed at each criterion. In Part Two, the whole sample was reassessed and (i) RR of PDD determined when two impairments at 1.5 s.d. existed within a single cognitive domain, followed by (ii) RR of PDD in the unique group whose two impairments at 1.5 s.d. did not exist within a single domain (i.e., only across two domains). Twenty-one percent of patients converted to PDD. Part One showed that the 1.5 s.d. criterion at baseline is optimal to maximize progression to PDD over 4 years. Part Two, however, showed that the 1.5 s.d. cutoff produced a high RR of PDD only when two impairments were identified within a single cognitive domain (7.2, 95% confidence interval (CI)=3.4–16.6, P<0.0001; 51% converted). The RR when the 1.5 s.d. impairments occurred only across two different domains, was nonsignificant (1.7, CI=0.5–7.4, P=0.13; 11% converted) and similar to using a 1 s.d. criterion (1.9, CI=0.3–4.3, P=0.13; 8% converted). If the intent of a PD-MCI diagnosis is to detect increased risk of PDD in the next 4 years, optimal criteria should identify at least two impairments at 1.5 s.d. within a single cognitive domain. |
format | Online Article Text |
id | pubmed-5516585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-55165852017-07-19 Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study Wood, Kyla-Louise Myall, Daniel J Livingston, Leslie Melzer, Tracy R Pitcher, Toni L MacAskill, Michael R Geurtsen, Gert J Anderson, Tim J Dalrymple-Alford, John C NPJ Parkinsons Dis Article The Movement Disorder Society Task Force (MDS-TF) has proposed diagnostic criteria for mild cognitive impairment in Parkinson’s disease (PD-MCI). We hypothesized that the risk of dementia (PDD) varies across the different cutoff schemes allowed. A longitudinal study followed 121 non-demented PD patients for up to 4.5 years. In Part One, unique groups of patients were identified as PD-MCI at baseline using the MDS-TF requirement of two impaired cognitive test scores, with both scores classified as impaired at either (i) 2 s.d., (ii) 1.5 s.d. or (iii) 1 s.d. below normative data; relative risk (RR) of PDD was assessed at each criterion. In Part Two, the whole sample was reassessed and (i) RR of PDD determined when two impairments at 1.5 s.d. existed within a single cognitive domain, followed by (ii) RR of PDD in the unique group whose two impairments at 1.5 s.d. did not exist within a single domain (i.e., only across two domains). Twenty-one percent of patients converted to PDD. Part One showed that the 1.5 s.d. criterion at baseline is optimal to maximize progression to PDD over 4 years. Part Two, however, showed that the 1.5 s.d. cutoff produced a high RR of PDD only when two impairments were identified within a single cognitive domain (7.2, 95% confidence interval (CI)=3.4–16.6, P<0.0001; 51% converted). The RR when the 1.5 s.d. impairments occurred only across two different domains, was nonsignificant (1.7, CI=0.5–7.4, P=0.13; 11% converted) and similar to using a 1 s.d. criterion (1.9, CI=0.3–4.3, P=0.13; 8% converted). If the intent of a PD-MCI diagnosis is to detect increased risk of PDD in the next 4 years, optimal criteria should identify at least two impairments at 1.5 s.d. within a single cognitive domain. Nature Publishing Group 2016-01-14 /pmc/articles/PMC5516585/ /pubmed/28725690 http://dx.doi.org/10.1038/npjparkd.2015.27 Text en Copyright © 2016 Parkinson's Disease Foundation/Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Wood, Kyla-Louise Myall, Daniel J Livingston, Leslie Melzer, Tracy R Pitcher, Toni L MacAskill, Michael R Geurtsen, Gert J Anderson, Tim J Dalrymple-Alford, John C Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study |
title | Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study |
title_full | Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study |
title_fullStr | Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study |
title_full_unstemmed | Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study |
title_short | Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study |
title_sort | different pd-mci criteria and risk of dementia in parkinson’s disease: 4-year longitudinal study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516585/ https://www.ncbi.nlm.nih.gov/pubmed/28725690 http://dx.doi.org/10.1038/npjparkd.2015.27 |
work_keys_str_mv | AT woodkylalouise differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT myalldanielj differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT livingstonleslie differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT melzertracyr differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT pitchertonil differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT macaskillmichaelr differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT geurtsengertj differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT andersontimj differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy AT dalrymplealfordjohnc differentpdmcicriteriaandriskofdementiainparkinsonsdisease4yearlongitudinalstudy |